Startup Company Finance

As business owners know, raising capital is essential to the survival and long-term success of startup and early-stage companies. Depending on its industry, stage of development, and the growth and exit goals of its principals, startup companies have numerous financing instruments from which to choose. From straightforward friends & family and seed financings, to multi-round convertible note financings and SAFEs, to more advanced series financing rounds with institutional investors, Sam has assisted clients big and small with all manner of early-stage investments.

Representative Transactions

  • Represented public-private partnership in more than two dozen equity and convertible debt investments in startup companies based in Missouri (2012-2020)
  • Regularly assisted startup companies in obtaining seed equity financing though St. Louis-based business incubator program (2015-2020)
  • Represented large national healthcare company in $5 million equity investment in healthcare software company (July 2020)
  • Represented men’s grooming products company in conversion to Delaware corporation and subsequent Series A financing round (June 2020)
  • Represented large national healthcare company in $5 million Series B-3 stock investment in digital technology healthcare company (May 2020)
  • Represented large national healthcare company in $5 million investment in an early stage healthcare investment fund (April 2020)
  • Represented large national healthcare company in $5 million Series B stock investment in Medicaid LTSS company (March 2020)
  • Represented Missouri-based consumer services technology company in conversion to Delaware corporation and subsequent participation in tech incubator program (November 2019)
  • Represented large national healthcare company in Series B-2 round investment in healthcare technology company (August 2019)
  • Represented St. Louis-based health care startup with conversion to Delaware limited liability company and subsequent founder equity incentive plan (August 2019)
  • Represented large national healthcare company in $5 million preferred stock investment in startup health services company (July 2019)
  • Represented regional grooming products company with Series Preferred Stock financing and subsequent conversion to Delaware corporation and Series A Preferred Stock financing (September 2018 – February 2019)
  • Represented small technology startup with friends and family financing round (December 2018)
  • Represented St. Louis-based technology company in Series A Financing round and related conversion to Delaware corporation (November 2018)
  • Represented investor in convertible note financing for a California-based retail purchasing app startup (July 2018).
  • Represented St. Louis-based tech company in $11.5 million Series B Preferred Stock financing (July 2018)
  • Represented Los Angeles-based investor in $2.7 million Series A round investment in California-based beverage services technology company (June 2018)
  • Represented large national healthcare company in $4 million note and warrant offering of startup health services company (April 2018)
  • Represented seed-stage food and beverage company in convertible note financing of approximately $1 million (March 2018)
  • Represented St. Louis-based web app company with multiple rounds of convertible note offerings (2015-2018)
  • Represented startup web app in Series A financing as part of a venture capital accelerator program (November 2017)
  • Represented large national healthcare company in $3 million investment in common stock of startup health services company (August 2017)
  • Represented St. Louis-based technology services company with $3.5 million Series Seed Preferred financing (July 2017)